The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions

被引:77
作者
Larsson, AJ
Walker, KJ
Raddatz, JK
Rotschafer, JC
机构
[1] ST PAUL RAMSEY MED CTR,SECT CLIN PHARM,ST PAUL,MN 55101
[2] UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455
关键词
D O I
10.1093/jac/38.4.589
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An in-vitro pharmacodynamic system was used to generate time-kill curves to demonstrate the concentration-independent pharmacodynamics of vancomycin against Staphylococcus aureus ATCC 29213. Initial vancomycin concentrations of 5, 10, 20 and 40 mg/L were studied monoexponentially while simulating a 6 h half-life. One parallel experiment was performed in duplicate using an initial peak concentration of 40 mg/L where both a distribution alpha-phase half-life of 0.66 h for 1 h and an elimination beta-phase half-life of 6 h for 11 h were simulated to determine if the transient distribution phase concentrations of vancomycin have any impact on bacterial killing beyond that provided by the elimination phase concentrations. Additionally, two monoexponential experiments with peak concentrations of 40 and 20 mg/L and a half-life of 6 h were repeated in an anaerobic chamber to determine if killing of S. aureus was affected. The time to achieve a 3 log(10) kill was calculated from the linear portion of the regression line and averaged (mean +/- S.D.) 9.0 +/- 1.4 h for all aerobic monoexponential experiments and was 8.4 and 8.6 h for the aerobic biexponential experiments (P > 0.05). For the anaerobic studies, the times to reach 3 log(10) kill were significantly greater averaging 18.9 +/- 1.7 h. The slopes of the bacterial kill curves were virtually identical for both monoexponential and biexponential aerobic experiments averaging -0.34 +/- 0.04, yet significantly different from the anaerobic bacterial kill curve slopes of -0.16 +/- 0.015 (P < 0.05). Time-kill curve analyses suggest that varying the concentration of vancomycin does not affect the rate or extent of bacterial killing aerobically or anaerobically against S. aureus and more efficient killing was achieved under aerobic conditions. The simulated distribution phase concentrations did not contribute to more effective killing of this strain of S. aureus.
引用
收藏
页码:589 / 597
页数:9
相关论文
共 23 条
[1]   ANALYSIS OF VANCOMYCIN TIME-KILL STUDIES WITH STAPHYLOCOCCUS SPECIES BY USING A CURVE STRIPPING PROGRAM TO DESCRIBE THE RELATIONSHIP BETWEEN CONCENTRATION AND PHARMACODYNAMIC RESPONSE [J].
ACKERMAN, BH ;
VANNIER, AM ;
EUDY, EB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1766-1769
[2]   VANCOMYCIN PROTEIN-BINDING IN PATIENTS WITH INFECTIONS CAUSED BY STAPHYLOCOCCUS-AUREUS [J].
ALBRECHT, LM ;
RYBAK, MJ ;
WARBASSE, LH ;
EDWARDS, DJ .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (7-8) :713-715
[3]  
[Anonymous], TXB CLIN APPL THERAP
[4]  
[Anonymous], M7A2 NCCLS
[5]  
CANTU TG, 1994, CLIN INFECT DIS, V18, P533
[6]  
CDC, 1993, MMWR-MORBID MORTAL W, V42, P597
[7]   RIGHT-SIDED STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN INTRAVENOUS DRUG-ABUSERS - 2-WEEK COMBINATION THERAPY [J].
CHAMBERS, HF ;
MILLER, RT ;
NEWMAN, MD .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (08) :619-624
[8]   VANCOMYCIN REVISITED [J].
COOK, FV ;
FARRAR, WE .
ANNALS OF INTERNAL MEDICINE, 1978, 88 (06) :813-818
[9]   SURVEY OF VANCOMYCIN MONITORING GUIDELINES IN ILLINOIS HOSPITALS [J].
FITZSIMMONS, WE ;
POSTELNICK, MJ ;
TORTORICE, PV .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (7-8) :598-600
[10]   ASSESSMENT OF EFFECTS OF PROTEIN-BINDING ON DAPTOMYCIN AND VANCOMYCIN KILLING OF STAPHYLOCOCCUS-AUREUS BY USING AN INVITRO PHARMACODYNAMIC MODEL [J].
GARRISON, MW ;
VANCEBRYAN, K ;
LARSON, TA ;
TOSCANO, JP ;
ROTSCHAFER, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (10) :1925-1931